                               SEQUENCE LISTING	

<110> X-BODY, INC.
 
<120> IDENTIFICATION OF NUCLEIC ACID DELIVERY VEHICLES USING DNA 
      DISPLAY

<130> 50736/002WO3

<140> PCT/US2010/024296
<141> 2010-02-16

<150> 61/225,664
<151> 2009-07-15

<150> 61/152,403
<151> 2009-02-13

<160> 13    

<170> PatentIn version 3.5

<210> 1
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
tactcatgcc atggccacca tgaacacgat taacatcgct aaga                        44


<210> 2
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
atgatacgcg gccgcttatt acgcgaacgc gaagtccga                              39


<210> 3
<211> 42
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
taatacgact cactataggg acaattacta tttacaatta ca                          42


<210> 4
<211> 78
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
tttttttttt tttttttttt aaatagcgga tgccttgtcg tcgtcgtcct tgtagtcggt       60

tggggcggat gcactccc                                                     78


<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ggttggggcg gatgcactcc c                                                 21


<210> 6
<211> 69
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
ttaaatagcg gatgctaagg acgacttgtc gtcgtcgtcc ttgtagtcgg ttggggcgga       60

tgcactccc                                                               69


<210> 7
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
atgatacgcg gccgcttatt acgcgaacgc gaagtccga                              39


<210> 8
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
tactcatgcc atggccacca tgaacacgat taacatcgct aaga                        44


<210> 9
<211> 64
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
atttaggtga cactatagaa gagtaatacg actcactata gggacaatta tatttacaat       60

taca                                                                    64


<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Biotin-Tyr

<400> 10
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 11
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Biotin-Lys

<400> 11
Lys Lys Trp Lys Met Arg Arg Asn Gln Phe Trp Val Lys Val Gln Arg 
1               5                   10                  15      


Gly 
    


<210> 12
<211> 43
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (21)..(21)
<223> t-NH2

<400> 12
tcctggctga ggcgagagtt tttctctcgc ctcagccagg acc                         43


<210> 13
<211> 56
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 13
ggatgccgaa tgcctaatac gactcactat agggacaatt actatttaca attaca           56


